Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) shares hit a new 52-week high on Tuesday . The stock traded as high as $30.59 and last traded at $29.90, with a volume of 557250 shares. The stock had previously closed at $28.00.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on PAHC shares. Morgan Stanley set a $26.00 price target on Phibro Animal Health and gave the company an "equal weight" rating in a research report on Wednesday, June 25th. JPMorgan Chase & Co. upgraded Phibro Animal Health from a "neutral" rating to an "overweight" rating and upped their price target for the stock from $25.00 to $35.00 in a research note on Monday. BNP Paribas Exane raised Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target for the company in a report on Monday, June 16th. Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Finally, BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $24.40.
Check Out Our Latest Report on PAHC
Phibro Animal Health Stock Performance
The stock's 50 day moving average price is $24.06 and its two-hundred day moving average price is $22.25. The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67. The firm has a market capitalization of $1.25 billion, a price-to-earnings ratio of 39.62, a PEG ratio of 0.50 and a beta of 0.75.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 30.51% and a net margin of 2.68%. The firm had revenue of $347.80 million during the quarter, compared to the consensus estimate of $352.41 million. On average, analysts forecast that Phibro Animal Health Corporation will post 1.95 EPS for the current year.
Phibro Animal Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th were given a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, June 4th. This represents a $0.48 annualized dividend and a dividend yield of 1.55%. Phibro Animal Health's dividend payout ratio is currently 61.54%.
Institutional Trading of Phibro Animal Health
A number of large investors have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its stake in shares of Phibro Animal Health by 0.4% during the first quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company's stock valued at $32,500,000 after buying an additional 6,784 shares during the period. Acadian Asset Management LLC boosted its position in shares of Phibro Animal Health by 0.5% in the first quarter. Acadian Asset Management LLC now owns 782,939 shares of the company's stock worth $16,713,000 after acquiring an additional 4,144 shares during the last quarter. American Century Companies Inc. increased its position in Phibro Animal Health by 18.0% during the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock worth $13,348,000 after purchasing an additional 96,787 shares during the last quarter. Nuveen Asset Management LLC boosted its holdings in shares of Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock valued at $12,348,000 after purchasing an additional 103,618 shares during the last quarter. Finally, Renaissance Technologies LLC grew its position in Phibro Animal Health by 1.9% during the fourth quarter. Renaissance Technologies LLC now owns 557,800 shares of the company's stock valued at $11,714,000 after acquiring an additional 10,600 shares during the period. Institutional investors and hedge funds own 99.34% of the company's stock.
About Phibro Animal Health
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Articles
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
